HealthWarehouse.com, Inc. HEWA
Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
HealthWarehouse.com, Inc. (OTCQB: HEWA) is a U.S.-based digital pharmacy and healthcare services company focused on the online distribution of prescription medications, over-the-counter products, pet medications, and healthcare supplies. The company operates primarily within the e-commerce healthcare and pharmacy sectors and is known for offering mail-order pharmacy services directly to consumers through its online platform. Its business model emphasizes transparent pricing, home delivery, and regulatory compliance within the licensed pharmacy industry.
The company’s primary revenue drivers are prescription fulfillment, generic pharmaceutical sales, and consumer healthcare product distribution through its online marketplace. HealthWarehouse.com serves retail consumers across the United States, particularly price-sensitive and uninsured customers seeking lower-cost pharmacy alternatives. The company evolved from a traditional pharmacy operation into a nationally recognized online pharmacy platform after obtaining accreditation and licensing that enabled interstate pharmaceutical distribution. Its positioning has historically centered on convenience, regulatory legitimacy, and cost competitiveness in comparison with traditional brick-and-mortar pharmacies.
Business Operations
HealthWarehouse.com conducts its operations primarily through its online pharmacy platform and licensed dispensing facilities in the United States. The company generates revenue through direct-to-consumer pharmaceutical sales, recurring prescription fulfillment, over-the-counter healthcare products, and related pharmacy services. Its operations are concentrated in the U.S. market, where it maintains compliance with federal and state pharmacy regulations governing prescription dispensing and medication delivery.
The company controls core pharmacy fulfillment infrastructure, e-commerce systems, customer service operations, and pharmaceutical sourcing relationships. Public filings and company disclosures indicate that HealthWarehouse.com has historically focused on expanding digital pharmacy capabilities and operational efficiencies rather than maintaining extensive international infrastructure. Data regarding major joint ventures or material international subsidiaries is limited in publicly available disclosures, and certain partnership information is not consistently detailed across available public sources.
Strategic Position & Investments
HealthWarehouse.com’s strategic direction has focused on expanding digital pharmacy adoption, increasing prescription volume, and strengthening its position in the online healthcare distribution market. The company has emphasized growth through technology-enabled pharmacy services, customer acquisition initiatives, and expansion of recurring prescription relationships. Public disclosures also indicate ongoing investment in e-commerce functionality, regulatory compliance systems, and fulfillment capabilities intended to support scalable direct-to-consumer operations.
The company operates in a healthcare environment increasingly influenced by telehealth adoption, digital prescription management, and consumer demand for lower-cost medication access. While HealthWarehouse.com has participated in broader digital healthcare trends, publicly available information regarding large-scale acquisitions, material portfolio investments, or extensive subsidiary ownership remains limited. Data inconclusive based on available public sources regarding significant recent acquisitions or venture investments.
Geographic Footprint
HealthWarehouse.com is headquartered in Florence, Kentucky, and primarily serves customers throughout the United States via mail-order and online pharmacy distribution. Its operational footprint is concentrated domestically, supported by pharmacy licensing and shipping capabilities that enable prescription fulfillment across multiple U.S. states. The company’s core market presence remains focused on North American consumers rather than international retail expansion.
Although the company operates within the broader digital healthcare sector, publicly available filings and disclosures do not indicate a substantial direct operational presence across Europe, Asia-Pacific, Latin America, or other international regions. Its influence outside the United States appears to be limited primarily to online accessibility rather than physical operations or foreign subsidiaries.
Leadership & Governance
HealthWarehouse.com has historically been led by executives with backgrounds in pharmacy operations, healthcare distribution, and e-commerce management. The company’s governance structure follows the framework typical of publicly traded healthcare and consumer services companies, including executive management oversight and board-level governance responsibilities. Strategic leadership has generally emphasized regulatory compliance, digital pharmacy expansion, and consumer affordability initiatives.
Key executives identified in public filings and company disclosures include:
- Joseph W. Peters – President and Chief Executive Officer
- John N. Ware – Chairman
- David A. Hinson – Chief Financial Officer
Additional executive and governance information may vary across reporting periods. Data inconclusive based on available public sources regarding certain recent management changes or expanded executive appointments.